Impact News +++ Greggs initiated at “overweight” as JPM flags valuation reset and strong unit econ (Investing.com) +++ GREGGS Aktie +4,58%

AVADEL Aktie

>AVADEL Aktienkurs

18.3 EUR (Tradegate)

Ask: 18.5 EUR / 216 Stück

Bid: 18.1 EUR / 222 Stück

Tagesumsatz: 0 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

AVADEL Aktie über LYNX handeln

Intraday

1 Jahr

>AVADEL Performance

1 Woche: -3,2%

1 Monat: +9,7%

3 Monate: +40,9%

6 Monate: +121,4%

1 Jahr: +91,5%

laufendes Jahr: +79,2%

>AVADEL Aktie

Name:

AVADEL PHARMACEUTICALS

Land:

Irland

Sektor:

Gesundheit

ISIN/ Wkn:

IE00BDGMC594 / A2DJ5B

Symbol/ Ticker:

AWK (Frankfurt) / AVDL (NASDAQ)

Kürzel:

FRA:AWK, ETR:AWK, AWK:GR, NASDAQ:AVDL

Index:

Webseite:

https://www.avadel.com/

Profil:

Avadel Pharmaceuticals plc is a healthcare company..
>Volltext..

Marktkapitalisierung:

1790.53 Mio. EUR

Unternehmenswert:

1744.35 Mio. EUR

Umsatz:

212.97 Mio. EUR

EBITDA:

7.03 Mio. EUR

Nettogewinn:

-0.24 Mio. EUR

Gewinn je Aktie:

Schulden:

32.03 Mio. EUR

Liquide Mittel:

68.4 Mio. EUR

Operativer Cashflow:

31.7 Mio. EUR

Bargeldquote:

1.47

Umsatzwachstum:

70.67%

Gewinnwachstum:

99.64%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

AVADEL

Letzte Datenerhebung:

05.12.25

>AVADEL Kennzahlen

Aktien/ Unternehmen:

Aktien: 97.82 Mio. St.

Frei handelbar: 95.52%

Leerverk. Aktien: 6.81%

Rückkaufquote: -0.23%

Mitarbeiter: 188

Umsatz/Mitarb.: 0.77 Mio. EUR

Analysten:

Analystenrating: Neutral

Kursziel: -1.86%

Bewertung:

KGV: -

KGV lG: 109.93

KUV: 9.08

KBV: 21.49

PEG-Ratio: -

EV/EBITDA: 248.26

Rentabilität:

Bruttomarge: 94.47%

Gewinnmarge: -0.11%

Operative Marge: 1.82%

Managementeffizenz:

Gesamtkaprendite: -0.16%

Eigenkaprendite: -0.32%

>AVADEL Peer Group

Es sind 10 Aktien bekannt.

>AVADEL Chart & Kurs - NASDAQ

>AVADEL News

26.11.25 - 17:30

ANNOUNCEMENT FOR THE PURPOSES OF ARTICLE 17 "MAR" RULES (EU) NO. 596/2014 (INSIDE INFORMATION) AND RULE 2.8 OF THE IRISH TAKEOVER PANEL ACT 1997, TAKEOVER RULES, 2022 (THE “IRISH TAKEOVER RULES”) (Cision)

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. H. Lundbeck A/S (“Lundbeck”) No offer for Avadel Pharmaceuticals plc (“Avadel”) Further to the announcement under Rule 2.7 of the Irish Takeover Rules by Avadel and Alkermes plc on November 19, 2025, Lundbeck confirms that it does not intend to make an offer for Avadel. Accordingly, Lundbeck will be bound by the restrictions set out in Rule 2.8 of the Irish Takeover Rules....

20.11.25 - 16:45	ALKS Raises Its Offer to Buy Avadel In Response to Lundbeck′s Proposal (Zacks)
	Alkermes lifts its bid to buy Avadel for $22.50 per share as its takeover fight with Lundbeck intensifies and shifts the deal's momentum....

20.11.25 - 16:06	UK Regulatory News: Zürcher Kantonalbank (EQS)
	Form 8.3 – Avadel Pharmaceuticals plc...

19.11.25 - 16:18	UK Regulatory News: Zürcher Kantonalbank (EQS)
	Zürcher Kantonalbank: Avadel Pharmaceuticals plc...

19.11.25 - 13:06	Alkermes raises Avadel buyout offer after Lundbeck’s unsolicited bid (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

19.11.25 - 12:03	Alkermes plc Announces Increased Offer to Acquire Avadel Pharmaceuticals plc (PR Newswire)
	NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION DUBLIN, Nov. 19, 2025 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) ("Alkermes") and......

18.11.25 - 18:15	Avadel Board Labels Lundbeck Acquisition Bid a Superior Proposal (Zacks)
	AVDL's board calls Lundbeck's higher $23-per-share bid superior to its Alkermes deal, triggering a critical five-day response window....

18.11.25 - 17:54	UK Regulatory News: Zürcher Kantonalbank (EQS)
	Form 8.3 – Zürcher Kantonalbank: Avadel Pharmaceuticals plc...

17.11.25 - 11:48	Avadel Board of Directors Declares Lundbeck Proposal a “Company Superior Proposal” (GlobeNewswire EN)
	THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014...

14.11.25 - 15:48	H. Lundbeck Launches Bid for Avadel in Move to Scuttle Alkermes Deal (WSJ EN)
	The unsolicited bid—worth up to $2.25 billion—potentially upends Avadel's deal to be acquired by Alkermes....

14.11.25 - 14:42	Stocks making the biggest premarket moves: Warner Bros. Discovery, Cidara Therapeutics, Avadel Pharmaceuticals and more (CNBC)
	These are some of the stocks posting the largest moves in premarket trading....

14.11.25 - 13:54	Alkermes Response to Avadel Announcement (PR Newswire)
	NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION. DUBLIN, Nov. 14, 2025 /PRNewswire/ -- Alkermes plc......

14.11.25 - 13:18	Avadel erhält höheres Übernahmeangebot – Aktie legt kräftig zu (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

14.11.25 - 13:00	Avadel climbs as Lundbeck outbids Alkermes in latest bidding war (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

14.11.25 - 12:48

ANNOUNCEMENT FOR THE PURPOSES OF RULE 2.12 OF THE IRISH TAKEOVER PANEL ACT 1997, TAKEOVER RULES, 2022 (THE “IRISH TAKEOVER RULES”) AND MAR ARTICLE 17 (INSIDE INFORMATION) (Cision)

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION H. Lundbeck A/S (“Lundbeck”) Possible offer for Avadel Pharmaceuticals plc (“Avadel”) Announcement for the purposes of Rule 2.12 of the Irish Takeover Rules and MAR article 17 (inside information) Further to the announcement made by Avadel under Rule 2.4 of the Irish Takeover Rules on November 14 2025, Lundbeck confirms that it has submitted a non-binding proposal to...

14.11.25 - 11:48	Avadel Receives Unsolicited Proposal from Lundbeck (GlobeNewswire EN)
	THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014...

05.11.25 - 17:15	FORM 8.1(a) & (b) - Avadel Pharmaceuticals plc (GlobeNewswire EN)
	U.K. DISCLOSURE, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Ap9...

23.10.25 - 18:00	ALKS to Enter Sleep Disorder Market With $2.1B Avadel Acquisition (Zacks)
	Alkermes inks $2.1B deal to acquire Avadel, adding the latter's Lumryz and new growth potential to its portfolio....

22.10.25 - 23:33	$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Avadel Pharmaceuticals plc (NASDAQ: AVDL) (PR Newswire)
	NEW YORK, Oct. 22, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The......

22.10.25 - 15:36	Alkermes übernimmt Avadel für 2,1 Milliarden Dollar – Aktie legt zu/n (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Die Sprache des Baus braucht man manchmal auch im Management. - Mag. Dr. Martin Kriegner

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram